Fortress Biotech Inc Pref Share FBIOP
Trading Information
- Previous Close Price
- $16.86
- Day Range
- $16.95–18.10
- 52-Week Range
- $6.27–21.43
- Bid/Ask
- $17.41 / $19.24
- Shares Outstanding
- —
- Market Cap
- $62.03M
- Volume/Avg
- 30,165 / 13,032
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 78
- Website
- https://www.fortressbiotech.com
Valuation
|
Metric
|
FBIOP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
FBIOP
|
|---|---|
Quick Ratio | 3.76 |
Current Ratio | 3.96 |
Interest Coverage | 20.92 |
Quick Ratio
FBIOP
Profitability
|
Metric
|
FBIOP
|
|---|---|
Return on Assets (Normalized) | 52.12% |
Return on Equity (Normalized) | 131.43% |
Return on Invested Capital (Normalized) | 72.10% |
Return on Assets
FBIOP
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|MdR^Z# | LOCK|DHLfk | $128B | |||
| Moderna Inc
MRNA
| LOCK|?xg#c^? | LOCK|qr | $81B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|^sqXdLM | LOCK|h%>?Y | $75B | |||
| argenx SE ADR
ARGX
| LOCK|!t&fs@l | LOCK|rR< | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|&%Wfzb | LOCK|>H% | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|>fN#$@R | LOCK|%g??y | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|ggqfBRz | LOCK|M$H$ | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|MQKrbG | LOCK|$@n | $25B | |||
| Incyte Corp
INCY
| LOCK|t@>wlL | LOCK|@dJ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|g?@K<wQ | LOCK|@Z$ | $15B |
United States